Cargando…

CD123 as a Therapeutic Target in the Treatment of Hematological Malignancies

The interleukin-3 receptor alpha chain (IL-3Rα), more commonly referred to as CD123, is widely overexpressed in various hematological malignancies, including acute myeloid leukemia (AML), B-cell acute lymphoblastic leukemia, hairy cell leukemia, Hodgkin lymphoma and particularly, blastic plasmacytoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Testa, Ugo, Pelosi, Elvira, Castelli, Germana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769702/
https://www.ncbi.nlm.nih.gov/pubmed/31547472
http://dx.doi.org/10.3390/cancers11091358